DDC and COVID-19: Kenneth Blum’s study found that dopamine synthesis might decrease in COVID-19, because SARS-Cov2 would induce down-regulation of angiotensin I converting enzyme 2 (ACE2) gene expression and the coexpression gene of dopa decarboxylase [26].